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License 4.0 (CC BY-NC).Cushing’s syndrome driver mutation disrupts protein
kinase A allosteric network, altering both regulation
and substrate specificity
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Kerstin Bathon3, Davide Calebiro4,5, Jiali Gao2,6, David A. Bernlohr1,
Susan S. Taylor7, Gianluigi Veglia1,2*D
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nloaded Genetic alterations in the PRKACA gene coding for the catalytic a subunit of the cAMP-dependent protein kinase A
(PKA-C) are linked to cortisol-secreting adrenocortical adenomas, resulting in Cushing’s syndrome. Among those, a
single mutation (L205R) has been found in up to 67% of patients. Because the x-ray structures of the wild-type and
mutant kinases are essentially identical, the mechanism explaining aberrant function of this mutant remains under
active debate. Using NMR spectroscopy, thermodynamics, kinetic assays, and molecular dynamics simulations, we
found that this single mutation causes global changes in the enzyme, disrupting the intramolecular allosteric network
and eliciting losses in nucleotide/pseudo-substrate binding cooperativity. Remarkably, by rewiring its internal alloste-
ric network, PKA-CL205R is able tobind andphosphorylate non-canonical substrates, explaining its changes in substrate
specificity. Both the lack of regulation and change in substrate specificity reveal the complex role of this mutated
kinase in the formation of cortisol-secreting adrenocortical adenomas. from o
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 INTRODUCTION
The cyclic adenosine monophosphate (cAMP)–dependent protein
kinaseA (PKA) plays a fundamental role in the function and replication
of endocrine cells (1), and aberrant cAMP signaling has been linked to
several endocrine diseases (2). The first mutations in PKA have been
found in the regulatory (R) subunits, which have been associated with
Carney complex, a multiple neoplasia syndromemanifesting via adreno-
cortical adenomas, cutaneous and neuronal tumors, cardiac myxomas,
and pigmented lesions of the skin and mucosae (2). Only recently
have somatic mutations been identified in the PRKACA gene coding
for the catalytic a subunit of PKA (PKA-C) and discovered in cortisol-
secreting adrenocortical adenomas responsible for Cushing’s syndrome
(2) (Fig. 1A). Nearly all identified mutations lie adjacent to the active site
cleft and the regulatory/catalytic subunit interface (Fig. 1, B and C).
Among these mutations, the most frequently found (PKA-CL205R) is a
point mutation leading to substitution of Leu at position 205 (or 206,
depending on the convention used for numbering) with Arg and has
been found in up to 67% of Cushing’s syndrome patients (3–7).
Inactive PKA exists as an inactive holoenzyme (R2C2) containing
an R-subunit dimer bound to two catalytic (C) subunits. The inhibi-
tory sequence of the R-subunit occupies the active site of the enzyme
(Fig. 1D). Upon stimulation of membrane receptors coupled to the
stimulatory Gs protein, produced cAMP binds to the R-subunits, un-
leashing active C-subunits (8). The spatiotemporal regulation of the
kinase is provided by ancillary proteins such as A-kinase anchoring
proteins that, via interactions with R-subunits, localize PKA-C in closeproximity to its substrates (9). In addition, PKA-C is regulated by an
endogenous inhibitor (PKI), whose function is to block access to sub-
strates and recruit PKA-C to the nuclear export complex (CRM1 and
RanGTP) (8). When this spatiotemporal regulation fails, PKA-C hy-
perphosphorylates its targets, leading to disease.
Structurally, PKA-C consists of two lobes. The N-lobe, smaller and
more dynamic, comprises mostly b strands, as well as the aC helix, and
harbors the adenosine 5′-triphosphate (ATP)–binding site (10). The
C-lobe, larger and made up of a helices, is more rigid and harbors the
substrate binding groove. PKA-C toggles between three major confor-
mational states: open (apo), intermediate (nucleotide-bound), and
closed (ternary complex with nucleotide/substrate-bound) (11). The
L205R mutation is located at the interface of the N- and C-lobes of
PKA-C in the P+1 loop, a highly conserved region of the enzyme that
creates a hydrophobic pocket for substrate docking. On the basis of its
positioning, the L205R mutation has been proposed and shown by
independent laboratories to disrupt the binding of R-subunits
and render the enzyme constitutively active (12, 13). In vivo studies
revealed that the catalytic activity of PKA-CL205R is comparable to that
of wild type (12). However, recent phosphoproteomic mapping
showed a drastic change in the phosphorylation profile, suggesting
that the mutation preserves the ability to phosphorylate downstream
substrates, althoughwith a different selectivity (14, 15). On the basis of
these data, it has been proposed that disruption of the signaling
network leading to the phosphorylation of non-canonical substrates
may contribute to tumorigenesis. Notably, the x-ray crystal structures
of the wild-type and mutant kinases in complex with nucleotide and
pseudo-substrate, PKI5–24, are nearly superimposable [root mean
square deviation (RMSD) = 0.49 Å] (16) and do not thoroughly ex-
plain the weaker binding for R-subunit, the lack of regulation by PKI,
and the changes in the phosphoproteomic profile.
To gain mechanistic insights into the multifarious effects of this
single mutation, we carried out solution nuclear magnetic resonance
(NMR) spectroscopy in concert with binding thermodynamics, ki-
netic assays, and molecular dynamics (MD) simulations. We found
that this single mutation, in addition to changing the protein-protein1 of 11
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 interface for substrate recognition, causes a disruption of the internal
allosteric communication, reducing its affinity for nucleotide. The
partial ablation of the intramolecular allosteric communication pre-
vents the kinase from reaching a completely closed state, reducing
the binding affinity for canonical substrates and pseudo-substrates,
thus hindering endogenous regulation. Notably, kinetic assays using
a substrate identified by phosphoproteomic analyses as a preferred
substrate of PKA-CL205R (14) show a higher catalytic efficiency and
a rearrangement of the internal structural dynamics and allosteric
communication. Together, our results indicate that rewiring of the in-
ternal allosteric network and global changes in dynamics contribute to
the complex dysregulation of the signaling network of PKA-CL205R
within tumor cells.RESULTS
PKA-CL205R shows a marked loss of binding cooperativity
between ATP and PKI
To determine the thermodynamics of nucleotide binding (ATPgN) to
both PKA-CWT and PKA-CL205R, we used isothermal titration calorim-
etry (ITC). We found that PKA-CL205R exhibits a threefold lower
binding affinity compared to PKA-CWT [Kd (dissociation constant) of
215 ± 15 mM versus 83 ± 8 mM, respectively]. Fitting of the titration
curves shows that the binding of ATPgN to PKA-CL205R is enthalpically
favorable and entropically unfavorable, whereas both contributions are
favorable for ATPgNbinding to PKA-CWT. To evaluate the binding co-
operativity between nucleotide and substrate (17, 18), we analyzed theWalker et al., Sci. Adv. 2019;5 : eaaw9298 28 August 2019binding thermodynamics of the pseudo-substrate peptide inhibitor,
PKI5–24, to both PKA-C
WT and PKA-CL205R in the presence and ab-
sence of nucleotide. DH, −TDS, DG, and Kd, as well as the cooperativity
coefficients (s) derived from ITC titrations, are summarized in table S1.
The binding thermodynamics of PKI5–24 to the apo forms of the two
kinases is comparable, with similar enthalpy changes (favorable).When
saturated with ATPgN, PKA-CWT binds PKI5–24 with higher affinity
(Kd = 0.16 ± 0.02 mM) (18). In contrast, PKA-C
L205R displays a 62-fold
reduction in binding affinity (Kd = 10 ± 3 mM), with a net decrease in
both DH and DS. The binding of PKI5–24 to the PKA-C
WT/ATPgN
complex is highly cooperative (s = 106 ± 18), whereas its binding co-
operativity to the PKA-CL205R/ATPgN complex decreases 18-fold
(s = 6 ± 2). Therefore, this single mutation affects both the affinity
for ligands and the binding cooperativity between nucleotide and
pseudo-substrate.
L205R mutation causes a reduction in
phosphorylation kinetics
To evaluate the catalytic efficiency of PKA-CL205R, we carried out
steady-state coupled assays using the standard substrate, Kemptide.
As expected from the binding thermodynamics and previous kinetic
assays, the Leu-to-Arg substitution at the P+1 loop increases the
KM (Michaelis constant) 11-fold (table S2). The kcat for the mutant
increases from 19 to 41 s−1, which results in an overall decrease in
catalytic efficiency (kcat/KM) by over fivefold compared to PKA-C
WT.
These results are in quantitative agreement with experiments carried
out by two other independent groups (16, 19).Gly-rich 
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Fig. 1. Architecture of PKA-C and locations of the Cushing’s syndromemutations. (A) Structure of PKA-C [Protein Data Bank (PDB) ID: 1ATP] in complex with pseudo-
substrate PKI depicting the location of Cushing’s mutations (yellow spheres) in relation to structural elements of the kinase. The E248Q mutation includes an additional
deletion (del243-247), and the S212R mutation includes an insertion (insIILR) not depicted. (B) X-ray structure of PKA-CL205R (PDB ID: 4WB6) with the overlay of PKI5–24
(PKIWT from PDB ID: 1ATP) describing the architecture of the peptide binding site and steric clash between kinase (PKA-CL205R) and pseudo-substrate. (C) Structure of
the R/C complex (PDB ID: 2QCS) depicting locations of Cushing’s mutations in relation to the pseudo-substrate inhibitory sequence of the R-subunit. (D) Primary
sequence comparison of common regulators (RIa, RIIb, and PKI) and peptide substrates of the catalytic subunit (Kemptide and VPS36).2 of 11
SC I ENCE ADVANCES | R E S EARCH ART I C L E
http://advances.scien
D
ow
nloaded from
 PKI binding to PKA-CL205R falls short in shifting the enzyme
to a fully closed state
To analyze the structural changes of PKA-C upon binding PKI and
the effects of the L205R mutation, we mapped the amide backbone
fingerprint of the enzyme using [1H, 15N]–TROSY (transverse
relaxation-optimized spectroscopy)–HSQC (heteronuclear single-
quantum coherence) experiments (20). The amide signatures of
the kinases in different ligated forms are displayed in fig. S1. The
binding of ATPgN to both PKA-CWT and PKA-CL205R gives rise to
similar chemical shift perturbations (CSPs), with the exception of
the residues in the Gly-rich, catalytic, and Mg2+ positioning loops
that show larger chemical shift changes for PKA-CWT (fig. S2). To
evaluate the global response to ligand binding for the kinase and its
mutant, we used CONCISE (coordinated chemical shifts behavior),
which performs a statistical analysis on linear chemical shift trajec-
tories of each amide resonance to identify the position of each state
along the conformational equilibrium (21). Following ligand
binding, the amide resonances of PKA-C display linear chemical
shift trajectories, with the amide resonances corresponding to the
apo enzyme populating one extreme and those of the closed state
(ternary complex with PKI) populating the opposite extreme of the
linear correlations. This behavior exemplifies a conformational
equilibrium along the three major conformational states of the ki-
nase (open, intermediate, and closed), whose relative populations
are modulated by ligand binding. A total of 55 residues exhibit
linear chemical shift trajectories for both PKA-CWT and PKA-
CL205R, indicating a fast exchange limit in the NMR chemical shift
time scale. These residues are distributed throughout the kinase.
We found that the binding of ATPgN and PKI shifts the confor-
mational equilibrium of PKA-CWT toward a fully closed state. InWalker et al., Sci. Adv. 2019;5 : eaaw9298 28 August 2019contrast, these ligands drive the mutant to a partially closed state,
which is located between the intermediate and closed conformation
(table S3). This is supported by thermostability data obtained by
circular dichroism (CD) measurements (table S4). CD melting
curves show that the PKA-CWT/ATPgN/PKI complex has a higher
melting temperature (Tm) than the corresponding complex with
PKA-CL205R, further suggesting that this complex may adopt a
more open and unstable conformation. Since the extent of the
closed state is correlated with binding affinity and cooperativity
(18), these results are consistent with the loss in allosteric coopera-
tivity revealed by thermocalorimetric data.
L205R disrupts the allosteric network of the kinase upon
PKI binding
To determine a possible correlation between the binding cooperativity
and the intramolecular allosteric network, we analyzed the correlated
CSPs for both PKA-CWT and PKA-CL205R using chemical shift co-
variance analysis (CHESCA) (22). This method identifies the allosteric
networks of residues that are involved in concerted responses to ligand
binding (23). The [1H, 15N]-TROSY-HSQC spectra of the three forms
ofwild-type and PKA-Cmutant (apo, ATPgNbound, andATPgN/PKI
bound) were used for the analysis. The CHESCA matrices for PKA-
CWT and PKA-CL205R reported in Fig. 2 (A and B) reveal remarkable dif-
ferences in their allosteric networks. There is an overall reduction in the
number of correlations throughout PKA-CL205R (Fig. 2, C and D), with
specific domains of the enzymemore affected by this single mutation. In
particular, residues belonging to the Gly-rich, activation loop and
peptide-positioning loop experience the most substantial reductions
in both number and extent of chemical shift covariation. In addition,
several interresidue correlations within the activation loop (W196), o
n
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(Q245) are also ablated. The loss of interresidue correlations for the
aFhelix is especially important as thismotif spans the hydrophobic core
of the C-lobe and is conserved throughout the AGC kinase family. The
function of the aF helix is to anchor all the hydrophobic motifs within
the kinase core and to orchestrate catalysis (24, 25). As highlighted
before, all Cushing’s driver mutations, with the exception of E31V,
are located near L205R and are likely to affect the enzyme in a similar
manner, disrupting these important allosteric nodes.
Binding of VPS36 substrate to PKA-CL205R rewires the
intramolecular allosteric network and reestablishes
binding cooperativity
In addition to affecting the regulation of PKA-C by the R-subunits,
L205R changes the kinase’s downstream substrate specificity (14, 15).
Specifically, it was found that in Escherichia coli, PKA-CL205R favors
noncanonical substrates with negatively charged residues (Glu or
Asp) at positions P+1, P+2, and P+3. Fromour own phosphoproteomic
studies on endogenous substrates in human cells (14), we identified sev-
eral substrates that are preferentially phosphorylated by the mutated
kinase. Among those substrates, we selected the top target hyperphos-
phorylated by PKA-CL205R: the vacuolar protein-sorting–associatedWalker et al., Sci. Adv. 2019;5 : eaaw9298 28 August 2019protein 36 (VPS36), a protein that plays a role in endosomal sorting
of ubiquinated cargo proteins by the endosomal sorting complex. The
recognition sequence of VPS36 (RRLSEEM) for PKA-C has two Glu
residues in the P+1 and P+2 positions. Using steady-state coupled
enzyme assays with Kemptide and a VPS36-derived peptide (residues
115 to 130 encompassing the PKA-C recognition sequence and denoted
VPS36 from hereon), we found that PKA-CL205R reduces the kinase’s
catalytic efficiency for Kemptide, which contains a hydrophobic residue
at the P+1 position. In contrast, the mutation causes an increase in kcat
(from 5 to ~18 s−1) forVPS36, leading to a threefold increase in catalytic
efficiency (Fig. 3A and table S2). In addition, the ITC analysis carried
out with VPS36 indicates that PKA-CL205R/ATPgN has an affinity typ-
ical of other substrates (Kd = 3.5± 0.1mM),while the binding towild type
cannot be detected reliably, suggesting a notably lower binding affinity
(table S1). A possible explanation is that the acidic residues in positions
P+1 andP+2 ofVPS36 hamper the intermolecular interactions between
the peptide and residues lining the binding pocket of PKA-CWT, while
they might favor the interactions with PKA-CL205R. These results sup-
port the proposed altered substrate specificity for PKA-CL205R detected
in intact cells.
To further investigate the underlying mechanism for the change in
substrate specificity of PKA-CL205R, we analyzed the trajectories of the o
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 amide resonances for the wild-type and mutated kinase upon binding
VPS36. Although VPS36 binding causes linear chemical shift changes
similar to PKI binding, the number of residues involved in the binding
response is substantially higher for PKA-CL205R. In addition, VPS36
binding causes an overall attenuation of the peak intensities throughout
the entire fingerprint of the enzyme, with some resonances broadened
beyond detection (fig. S3). For instance, resonances associated with
the aF helix and Gly-rich loop are noticeably broadened, suggesting
an increase in protein dynamics in the microsecond to millisecond
time scale. The CONCISE analysis shows that the conformation of
the PKA-CWT/ATPgN/VPS36 complex only reaches the intermediate
state. In contrast, the PKA-CL205R/ATPgN/VPS36 complex reaches a
state lying between the intermediate and closed states (Fig. 3B). This
position in between the intermediate and closed states was also ob-
served in the crystal structure of PKA-CWT bound to a substrate pep-
tide (26), suggesting that the ternary complex of PKA-CL205R with
VPS36 adopts a catalytically committed state.
The CHESCA maps for VPS36 binding to PKA-CWT and PKA-
CL205R are radically different (Fig. 3, C and D). While the PKA-CWT/
ATPgN/PKI complex shows an intense cross-talk between the small
and large lobes, the corresponding map for PKA-CWT/ATPgN/
VPS36 reveals a complete loss of allosteric interactions. Notably, corre-
lations between the nucleotide binding site and the substrate binding
hub are completely missing. In particular, the interresidue correlations
for the activation loop, peptide-positioning loop, and the aF and aG
helices are either reduced in their number or completely missing. In
contrast, a number of correlations between the N- and C-lobes for
PKA-CL205R, which are absent for the complex with PKI, are regained
upon VPS36 binding. Note that 10 of the resonances corresponding to
residues located in and around the Gly-rich loop are broadened beyond
detection and could not be included in the CHESCA analysis; therefore,
the extent of coordinated changes in chemical shifts is largely underes-
timated. Nonetheless, the higher density of correlations found in the
PKA-CL205R/ATPgN/VPS36 complex underscores an extensive rewir-
ing of the internal allosteric network, supporting the reestablished
binding cooperativity.
PKA-CWT and PKA-CL205R explore different
conformational states
To determine the effects of the L205R mutation on the conformational
energy landscape of PKA-C, we carried out parallel MD simulations of
the ternary complexes in explicit water environments starting from
their respective x-ray coordinates [Protein Data Bank (PDB) IDs:
4WB6 and 1ATP] (16). The dominant motion of the kinase core was
imaged using principal components analysis (PCA) of the Ca atoms en-
compassing residues 50 to 300. PC1 depicts the global opening-closing
motion of the small and large lobes (fig. S4A), while PC2 describes the
shearing motion of the two lobes that can be envisioned as an
“asymmetric bite.”To describe the opening-closingmotion of the active
site, we monitored the time dependence of the distance between the Ca
atoms of S53 in the Gly-rich loop and G186 (fig. S4, B and C). The
binary and ternary complexes of PKA-CWT and PKA-CL205R sample
similar conformational energy basins; however, the apo form of
PKA-CL205R explores a considerably broader basin than the wild type.
The Gly-rich loop of PKA-CWT toggles between the open and closed
conformations, featuring a transient hydrogen bond between S53 and
the g-phosphate of ATP, whereas the Gly-rich loop of PKA-CL205R
exhibits larger motions with the S53-G186 distance ranging from 5 to
18 Å and, more frequently, samples a conformation that hinders nucle-Walker et al., Sci. Adv. 2019;5 : eaaw9298 28 August 2019otide binding, whichmight explain its weaker binding affinity (Fig. 4A).
R205 causes steric hindrance with the C-terminal tail of PKI, disrupting
the hydrophobic pocket required to anchor the Ile residue in the P+1
position, which likely contributes to the loss of PKI binding affinity.
To visualize the alterations of the protein-protein interaction
interface that may influence binding cooperativity, we analyzed
the probability distribution of the inter-residue contacts between
the substrate and the kinase binding pocket. Overall, PKA-CL205R
shows a contact map with PKI similar to the wild-type enzyme (fig.
S5, A and B). The high-affinity binding region (HAR) and the con-
sensus binding sequences remain bound throughout the entire MD
trajectories with a probability of contact greater than 0.8. However,
the L205R mutation reduces the probability of interactions between
the Ile (at position P+1 in PKI) and the P+1 loop from 0.5 to 0.2.
In contrast, VPS36 shows stable interactions with the P+1 loop with
a probability greater than 0.8 for Glu at the P+1 position and R205
(fig. S5C). Moreover, the N terminus of VPS36 forms transient inter-
actions with the C-terminal tail located in the small lobe of PKA-
CL205R, which are absent in the corresponding complex with PKI.
As a result, the peptide is more dynamic, a feature that might explain
the dramatic exchange-broadening in the NMR spectrum of the PKA-
CL205R/ATPgN/VPS36 complex.
As observed previously (27), the backbone of the tertiary complex
PKA-CWT/ATP/PKI ismostly rigid (fig. S5,D andF). The activation loop
adopts a stable conformation as in the x-ray structure (PDB ID: 1ATP)
(28) throughout the entire MD simulation with an RMSD of ~1.5 Å. In
contrast, the activation loop and the adjacent loop that is anchored to the
aF helix (residues 210 to 220) in the corresponding PKA-CL205R/ATP/
PKI complex are more flexible, adopting two distinct conformations in
which the most populated is similar to the x-ray structure (PDB ID:
1ATP) and a second minor flipped conformation (Fig. 4B). In this con-
formation, the activation loop no longer interacts with the C-lobe and
forms a salt bridge with E86 of the aC helix (Fig. 4, D and E). For the
PKA-CL205R/ATP/VPS36 complex, the activation loop becomes more
ordered and the flipped configuration becomes dominant. The existence
of these two conformations is corroborated by chemical shift trajectories
observed for the indole resonance of W196 in the activation loop (Fig.
4C). Upon ligand binding, the indole resonance ofW196 follows a linear
chemical shift trajectory from the apo to the ternary form. This confor-
mational change is highly correlatedwith the othermajor allosteric nodes
(CHESCA plots), indicating that it follows the cooperative structural
changes of the enzyme. In contrast, the CHESCA plots for PKA-CL205R
show no correlations for these loops/residues, suggesting that the L205R
mutation disrupts the internal allosteric network and may dislodge the
activation loop from the large lobe.
The disruption of the allosteric network is mirrored by the pairwise
mutual information plots (29) obtained from the analysis of the MD
trajectories. For the wild-type enzyme, there are strong inter-residue
correlations throughout the entire core of the kinase, especially among
key catalytic motifs such as the Gly-rich loop (S53), the activation loop
(R194, W196), and the aF (Y215), aG (D241), and aH (N283) helices,
as well as the PIF motif at the C-terminal tail (F347) (fig. S6A). In con-
trast, PKA-CL205R lacks a number of allosteric interactions within the
N-lobe, with only a few correlations between the activation loop and the
C-lobe (fig. S6B). As for the CHESCA correlation maps, the mutual
information plots reveal that the allosteric network between the N-lobe
and C-terminal tail of PKA-CL205R is partially recovered upon VPS36
binding (fig. S6C) with the engagement of E91 in the aC helix and S53
of the Gly-rich loop.5 of 11
SC I ENCE ADVANCES | R E S EARCH ART I C L E
 o
n
 O
ctober 15, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 DISCUSSION
The L205R mutation was discovered independently in our laboratory
and in other laboratories as the dominant genetic alteration in cortisol-
producing adrenocortical adenomas responsible for Cushing’s syn-
drome (3–7). Although it has a direct link with changes in cAMP/PKA
signaling, adrenal Cushing’s syndrome has different molecular etiologies
(2). Initially, rare germline mutations were found in the PRKAR1A gene
encoding the regulatory Ia subunit of PKA in patients with Carney
complex (30). Most of these mutations occur at the interface between
the R- andC-subunits or near the cAMP-binding site in cyclic nucleotide
binding (CNB) domain A and are thought to cause aberrant regulation
of the kinase (31). Only recently has the focus shifted toward somatic
mutations occurring in the C-subunit of the enzyme. Even in this case,
mostmutated residues reside at the interface of the R/C complex. How-
ever, the molecular mechanisms for the aberrant regulation of cAMP
signaling by these mutations have been a matter of debate. Specifically,
two independent studies suggested that the L205Rmutation interferes
with the formation of the holoenzyme, rendering the C-subunit
constitutively active (3, 6). Sato et al. (4), on the other hand, proposed
that this mutation does not interfere with the R-subunit regulation and
that the development of the pathology is linked to intrinsic higher phos-
phoryl transfer activity of the mutant kinase. Recent studies both in
vitro and in intact cells have put forward a possible new mechanism,
suggesting that the mutated enzyme has altered substrate specificity
(14, 15, 19). Notably, this arginine preceding the APE motif (residues
206-208) is characteristic in the CMGC kinase family and assumes a keyWalker et al., Sci. Adv. 2019;5 : eaaw9298 28 August 2019role in substrate recognition and kinase activation (32). Perhaps PKA-
CL205R might lead to promiscuity toward substrates of CMGC kinases.
Our studies reveal that the dysfunction of PKA-CL205R is multifa-
ceted, whereby allosteric cooperativity is reduced, substrate specificity
is altered, and canonical regulation is ablated. The L205Rmutation dis-
rupts the hydrophobic interactions between the enzyme and substrate,
causing a dramatic decrease in PKI binding affinity. This is in line with
the impaired binding of the R-subunits found in our previous study (12)
as PKI and R-subunits share similar consensus sequences. Our CHESCA
analyses reveal that L205R perturbs the allosteric network of PKA-C
and disrupts specific allosteric nodes that connect the small and large
lobes. The allosteric nodes are defined as the hotspots in the network
with the highest number of CHESCA correlations (33). In particular,
the allosteric communication between the node including L205 and en-
compassing the activation loop and aF and aG helices and the node
surrounding the Gly-rich loop, b2, and b3 is ablated. Closer analysis
of the CHESCA map of PKA-CWT reveals that each allosteric node
harbors Cushing’s mutations located in the activation/aF/aG node ex-
cept E31V, where the latter resides at the N-terminal aA helix, a unique
regulatory motif in PKA-C (Fig. 5A) (34). Although spatially distinct,
these allosteric nodes are highly correlated and coupled to one another to
facilitate intramolecular communication and control binding cooperativ-
ity. Perturbation to one node, such as the case of L205R, has long-range
effects on the other node. The latter suggests that Cushing’s mutations
including E31Vmay disrupt the allosteric communication eliciting simi-
lar global responses in terms of binding cooperativity and regulation.A
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 The CHESCA analyses of the chemical shifts parallel the predictions
obtained fromMD simulations using the community analysis. Analyz-
ing the different forms of the kinase, McClendon et al. (35) identified
allosterically linked communities within PKA-C, each associated with a
particular function or regulatory mechanism. Plotting correlated resi-
dues on PKA-C’s community maps reveals that the mutation dramat-
ically reduces the allosteric communication between communities A, D,
and Fwith respect to thewild-type enzyme (Fig. 5, B andC). In contrast,
binding of VPS36 to PKA-CL205R reestablishes the intercommunity
communication and the allosteric network.
The lack of regulation only partially explains the aberrant function of
PKA-CL205R. Our thermodynamic and kinetic analyses reveal that this
mutation shifts the specificity of PKA-CL205R toward substrates con-
taining acidic residues in the P+1 and P+2 positions, with a dramatic
effect on binding cooperativity. While the cooperativity is greatly abol-
ished with the classical consensus sequence, the mutated enzyme re-
gains cooperativity with complementary substrates such as VPS36,
among others. The reason for this behavior is apparent from the atomic
mapping of the cooperative global response of the enzyme to ligand
binding. While the allosteric communication between the N-lobe,
harboring the ATP binding site, and the C-lobe, with the substrate
binding site, is abolished with the classical consensus sequence, the
binding of the complementary substrate (VPS36) coincides with an
extensive rewiring of the allosteric network of communication be-
tween the two lobes, altering substrate specificity. It should be notedWalker et al., Sci. Adv. 2019;5 : eaaw9298 28 August 2019that VPS36 lacks the HAR, whichmight affect its binding kinetics and
thermodynamics. As with previous studies (17), VPS36 does not drive
the enzyme to a completely closed state, perhaps facilitating product
release. The reduction of the binding affinity for the nucleotide we
observed under our experimental conditions was also detected by
Luzi et al. (19). Taken with our NMR and thermodynamic studies,
MD simulations suggest that the mutation changes the energy land-
scape of the kinase (Fig. 6). First, the mutation causes a reduction in
binding affinity for nucleotide, which may be due to an increase in
the population of the enzymewith the Gly-loop partially occluded. This
conformation has been detected in other crystal structures and might
prevent the nucleotide to intercalate in the C-spine of the enzyme
(36). Moreover, a significant population of the enzyme spans a confor-
mational space featuring a flipped conformation of the activation loop
and a salt bridge formed between R194 and E86 in the aC helix. Nota-
bly, an increased plasticity of the activation loop, highlighted byW196,
contributes to disruptions in the docking surface with the R-subunit
(37). At the same time, the R194-E86 salt bridge suggests a different
dynamic coupling between the activation loop and the aC helix. It is
possible that this specific conformational state might dictate the selec-
tivity of the substrate binding and the aberrant profile observed in phos-
phoproteomic assays.
Given the ubiquitous nature of PKA and its involvement in numer-
ous cell signaling events, its implication in specific diseases has been
overlooked. Only recently, the attention of researchers has beenA Missing correlations for PKA-CL205R
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 directed to the PRKACA gene and its role in pathological lesions. A
few years ago, Simon and co-workers discovered the presence of a chi-
meric construct of the PKA-C subunit that is the main driver of fibro-
lamellar hepatocellular carcinoma (38). Later on, our group and others
discovered single mutations or insertions at the R/C interface that are
linked to adrenal Cushing’s syndrome (3–7). More recently, Tseng et al.
(39) reported the discovery of a new insertion in a similar region that is
involved in the development of myxoma, a sporadic form of tumor
in the atrium of the heart. It is possible that other defects in the
PRKACA gene might be found to be implicated in the development
of other tumors.
The analysis of the allosteric network carried out in this work reveals
highly coupled allosteric nodes that harbor all Cushing’s mutations
found in patients and may help to explain why mutations located in
two spatially distinct regions of the enzyme result in the same pheno-
type. Our findings suggest that analysis of allosteric networks using
CHESCA may prove useful in predicting mutations that perturb cata-
lytic function for enzymes beyond PKA-C. Furthermore, our work re-
veals that rewiring of the intra- and intermolecular interactions leads to
changes in cooperativity and selectivity. This suggests the opportunity
to exploit smallmolecules or peptides that can change the internal com-
munication andmodulate the activity of this aberrant mutant selective-
ly, i.e., without affecting the function of the wild type.MATERIALS AND METHODS
Sample preparation
The recombinant human Ca subunit of cAMP-dependent PKA cDNA
(PKA-CWT and PKA-CL205R) was cloned into a pET-28a vector. AWalker et al., Sci. Adv. 2019;5 : eaaw9298 28 August 2019tobacco etch virus (TEV) cleavage site was incorporated via muta-
genesis into the vector between the cDNA coding for the kinase
and a thrombin cleavage site. The kinase was expressed in E. coli
BL21 (DE3) pLysS cells in M9 minimal media supplemented with
15NH4Cl. Protein overexpression was induced with 0.4 mM iso-
propyl b-D-thiogalactopyranoside and carried out overnight at 20°C.
PKA-C purification was carried out using Ni2+ affinity chromatogra-
phy. Cells were lysed using a French press in 50 mM tris-HCl, 30 mM
KH2PO4, 200 mM NaCl, 200 mM ATP, 5 mM 2-mercaptoethanol,
and lysozyme [lysis buffer (15 mg/100 ml)] (pH 8.0). After removing
cell debris by centrifugation at 18,000 rpm for 45 min, the super-
natant was incubated with Ni2+ nitrilotriacetic acid resin (Thermo
Fisher Scientific) at 4°C overnight. The resin was washed with 50 mM
tris-HCl, 30 mM KH2PO4, 200 mM NaCl, 10 mM imidazole, and
5 mM 2-mercaptoethanol (pH 8.0) and eluted with 50 mM tris-
HCl, 30 mM KH2PO4, 200 mM NaCl, 250 mM imidazole, and 5 mM
2-mercaptoethanol (pH 8.0). Fractions containing PKA-C were cleaved
overnight at 4°C with a sufficient amount of recombinant TEV while
being dialyzed into 20 mM KH2PO4, 25 mM KCl, 0.1 mM phenyl-
methylsulfonyl fluoride, and 5 mM 2-mercaptoethanol (pH 6.5). The
three isoforms of PKA-C (corresponding to the three phosphorylation
stateswith identical catalytic parameters)were separated by chromatog-
raphy on a HiTrap SP column (GE Healthcare Life Sciences) using a
linear gradient from buffer A [20mMKH2PO4 (pH 6.5)] to 30% buffer
B [20 mM KH2PO4 and 1 M KCl (pH 6.5)] at a flow rate of 2 ml/min.
Isoform II with pThr197, pSer338, and pSer10 was used for all NMR
experiments. Peptides (Kemptide/PKI5–24/VPS36) were synthesized
using standard Fmoc chemistry on a CEM Liberty Blue microwave
synthesizer, cleaved with Reagent K (82.5% trifluoroacetic acid, 5%
phenol, 5% thioanisole, 2.5% ethanedithiol, and 5%water) for 3 hours,
and purified using a semipreparative Supelco C18 reverse-phase
HPLC column at 3 ml/min. The VPS36 peptide sequence used for
all studies is as follows: QIEFYRRLSEEMTQR. The molecular weight
and quantity of the peptides were verified by liquid chromatography–
mass spectrometry and/or amino acid analysis (Texas Tech Protein
Chemistry Laboratory).
ITC measurements
ITC measurements were performed with a low-volume Nano ITC (TA
Instruments). PKA-CWT and PKA-CL205R were dialyzed into 20 mM
Mops, 90 mM KCl, 10 mM dithiothreitol (DTT), 10 mM MgCl2, and
1 mM NaN3 (pH 6.5). PKA-C concentrations for ITC measurements
were between 100 and 130mMas confirmed byA280 = 53,860M
−1 cm−1.
All measurements with ATPgN-saturated PKA-CWT and PKA-CL205R
were performed at 2 mMATPgN and 4mMATPgN, respectively. ITC
measurements were performed at 300 K in triplicate. Approximately
300 ml of PKA-C was used for each experiment, as well as 50 ml of 2
to 4 mM ATPgN, 0.6 to 4 mM PKI, or 2 mM VPS36 in the titrant sy-
ringe. The heat of dilution of the ligand into the buffer was taken into
account for all experiments and subtracted accordingly. Binding was
assumed to be 1:1, and curves were analyzed with the NanoAnalyze
software (TA Instruments) using the Wiseman isotherm (40)
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Fig. 6. Schematic of the energy landscape for PKA-CWT and PKA-CL205R,
combining thermodynamics and MD simulations data. Relative free energy for
the binding of ATPgN, PKI, and VPS36 to PKA-CWT and PKA-CL205R derived from
ITCdata. (1) Apo PKA-CL205R samplesmostly uncommitted states, with theGly-rich loop
partially occluded and the aC helix turned outward. (2) Binary PKA-CL205R features a
wired allosteric network for substrate binding, i.e., committed state. (3) Ternary PKA-
CL205R complex with lower affinity for PKI (i.e., higher free energy relative to PKA-CWT).
The conformation of the activation loop of PKA-CL205R is in equilibrium between an
unflipped and a sparsely populated flipped conformation. (4) PKA-CL205R/ATPgN/
VPS36 ternary complex features a flipped conformation of the activation loop with
the electrostatic interactions between E86 and R194.8 of 11
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 with respect to the total protein concentration) and RM (the ratio be-
tween total ligand and total protein concentration). The free energy
of binding was determined using the following
DG ¼ RT lnKd
where R is the universal gas constant and T is the temperature at mea-
surement (300 K). The entropic contribution to binding was calculated
using the following
TDS ¼ DH  DG
Calculations for the cooperativity constant (s) were calculated as
follows
s ¼ Kd Apo
Kd Nucleotide
where Kd Apo is the Kd of PKI5–24 binding to the apoenzyme and Kd
Nucleotide is the Kd of PKI5–24 binding to the nucleotide-bound enzyme.
Enzyme assays
Steady-state activity assays with Kemptide and VPS36 were per-
formed under saturating ATP concentrations and spectrophoto-
metrically at 298 K, as described by Cook et al. (41). The values of
Vmax and KM were obtained from a nonlinear fit of the initial velocities
to the Michaelis-Menten equation.
Circular dichroism
A change in ellipticity was measured at 220 nm on a Jasco J-815 spec-
trometer. A temperature scan between 20° and 70°C at a rate of 1°C/min
with an equilibration time of 15 s was performed to unfold the protein.
Spectra Manager Pro software was used to fit a two-state sigmoidal
function. The inflection point was taken as the Tm (in °C), the point
at which 50% of the protein is folded.
NMR spectroscopy
Uniformly 15N-labeled PKA-CWT and PKA-CL205R were overexpressed
and purified as described above. NMR experiments were performed
in 90 mM KCl, 20 mM KH2PO4, 10 mM DTT, 10 mM MgCl2, and
1 mM NaN3 at pH 6.5. Standard [
1H, 15N]-TROSY-HSQC experi-
ments were carried out for PKA-CL205R and PKA-CWT on 600-MHz
and 900-MHz Bruker Avance III spectrometers equipped with TCI
cryoprobes, respectively. Concentrations for sampleswere 0.2 to 0.3mM
as determined by A280 measurements, 12 mMATPgNwas added for
the nucleotide-bound form, and 0.2 to 1.2 mM PKI or 0.4 to 1.8 mM
VPS36 was added for the ternary complex. Full-length PKI was used
for all NMR experiments and subsequent analyses. Spectra were
collected at 300 K, processed using NMRPipe (42), and visualized
using Sparky (43).
All [1H, 15N]-TROSY-HSQC experiments were acquired with
2048 (proton) and 256 (nitrogen) complex points. Spectra acquired
in complex with VPS36 were acquired with substantially more scans
(NS= 96) compared to other spectra [number of scans (NS) = 32 to 64].
Combined CSPs were calculated using 1H and 15N chemical shifts
according to the following
Dd ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðDdHÞ2 þ 0:154ðDdNÞ2
q
ð2ÞWalker et al., Sci. Adv. 2019;5 : eaaw9298 28 August 2019Changes inCSPswere calculated according to the following for both
nucleotide binding and pseudo-substrate binding
DCSP ¼ DdWT  DdL205R ð3Þ
Chemical shift analyses
Coordinated chemical shifts behavior
CONCISE was used to monitor chemical shift trajectories and mea-
sure the change in equilibrium position using each PKA-C construct
(apo, ATPgN, ATPgN/PKI, and ATPgN/VPS36). Using PCA, this
method identifies sets of residues whose chemical shifts respond lin-
early to the conformational transition. Each residue provides a mea-
sure of the equilibrium position for every PKA-C construct in the
form of scores along the first principal component (PC1). The equi-
librium position for a given construct is given by the average of all
principal component scores over all linear residues. To identify the
residues whose chemical shifts follow a linear trajectory, a threshold
of 3.0 for the ratio of the SDs of PC1 over PC2 was used, and residues
not exhibiting a significant chemical shift were excluded based on line-
width. After this threshold was applied, a total of 55 residues formed
the subset that was used to trace the equilibrium position of each state
for PKA-CWT and PKA-CL205R.
Chemical shift covariance analysis
CHESCA was used to identify and functionally characterize allosteric
networks of residues eliciting concerted responses to, in this case, nucle-
otide, pseudo-substrate, and substrate. A total of three states were used
to identify inter-residue correlations: apo, ATPgN-bound, and either
ATPgN/PKI- or ATPgN/VPS36-bound. Identification of inter-residue
correlations by CHESCA relies on agglomerative clustering and
singular value decomposition. Pairwise correlations between chemical
shift variations experienced by different residues are analyzed to identify
networks of coupled residues and, when plotted on a correlationmatrix,
allow for the identification of regions that are correlated to one another.
A correlation coefficient cutoff of 0.98 was used to filter nonlinear res-
idues. Residues not exhibiting a significant chemical shift (small shifts
in parts per million) were excluded based on linewidth. Linewidth was
calculated for each resonance in each of the three forms (apo, ATPgN,
and ATPgN/PKI or ATPgN/VPS36). For each residue, the maximum
change in chemical shift was calculated in both the 1H (x) and 15N (y)
dimension (Ddx,y). Residues were included in CHESCA analysis only if
they satisfied the following: Ddx,y >½ DnxA,yA +½Dn xB,yB, whereA and
B correspond to two different forms analyzed (note that there is no
dependence on which two forms satisfied this statement).
MD simulations
System setup on wild type and L205R
We used the crystal structure of PKA-CWT (PDB ID: 1ATP) (28) and
PKA-CL205R (PDB ID: 4WB6) (16) as the template and chose a mono-
mer (chain A, protein; chain I, PKI5–24) from the dimer. We further
aligned the current structure with the full-length PKA-CWT and added
the missing residues 1 to 12 at the N terminus. The protonation state of
histidine residues followed our previous settings (27). The protein was
solvated in a rhombic dodecahedron solvent box with a TIP3P water
molecule layer extended approximately 10 Å away from the surface
of the proteins. Counter ions (K+ and Cl−) were added to ensure
electrostatic neutrality corresponding to an ionic concentration of
~150 mM. All protein covalent hydrogen bonds were constrained with
the LINCS (linear constraint solver) algorithm, and long-range
electrostatic interactions were treated with the particle-mesh Ewald9 of 11
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 method with a real-space cutoff of 10 Å. Parallel simulations on the apo
form, the binary formwith oneMg2+ ion and one ATP, and the ternary
form with two Mg2+ ions, one ATP, and one PKI5–24 were performed
simultaneously using GROMACS 4.6 (44) in CHARMM36a1 force
fields (45). Each system was minimized using the steepest decent
algorithm to remove the bad contacts and then gradually heated to
300 K at a constant volume over 1 ns, using harmonic restraints with
a force constant 1000 kJ/(mol·Å2) on heavy atoms of both proteins and
nucleotides. Over the following 12 ns of simulations at constant pres-
sure (1 atm) and temperature (300 K), the restraints were gradually re-
leased. The systems were equilibrated for an additional 20 ns without
positional restraints. A Parrinello-Rahman barostat was used to keep
the pressure constant, while a V-rescale thermostat with a time step
of 2 fs was used to keep the temperature constant. Each system was
simulated for 1.05 ms, with snapshots recorded every 20 ps. A total
of 3.15 ms and 157,500 conformations were used for the analyses.
Energy landscapes using PCA
Cartesian principal components of the backbone atoms were calculated
using the GROMACS modules g_covar and g_anaeig to identify the
large-scale, low-frequency conformational dynamics of the catalytic
core. All the trajectories were aligned with the starting structure (min-
imization of the crystal structure to remove bad contacts) using helices E
(residues 140 to 160) and F (residues 217 to 233) as a reference frame.
Dominant principal components were computed from each resulting
ensemble from the individual simulations. Moreover, the distance be-
tween the Ca atom of Ser53 and Gly186 was measured to characterize
the opening and closing motions of the Gly-rich loop. Different trajec-
tories were mapped onto the 2D projection along PC1 and S53-G186
distances.
Docking and simulation of the ternary complexes bound with
VPS36 peptide and ATP
We used the unwound conformation of VPS36 and used HADDOCK
(46) server for docking into the binding cleft of PKA-C for both wild
type and L205R. Specifically, we used the easy interface and selected the
active residues of PKA-C, i.e., 133, 168, 202, 198, 204, 205, 207, 230, and
330, as well as the active residues for VPS36, i.e., 3, 6, 7, 9, and 10. The
passive residueswere set automatically around the active residues by the
server. The top-scored structures were further solvated for MD simula-
tions following the same protocol as the ternary complexes with PKI.
Mutual information analysis and mapping of the
allosteric network
Tomonitor the allosteric differences of thewild type and L205R,MutInf
(29) was used to compute mutual information between all residues.
MutInf is a python package that translates the distribution of dihedral
angles of residues into their conformational entropy and identifies the
correlated motions between residues. The time series of dihedral angles
in the MD ensemble was computed using g_chi and divided into six
overlapped blocks, and then, correlations of local motions were com-
puted as the mutual information between selected residue pairs in each
block. The results were averaged over these blocks to filter out the cor-
relations that were not statistically significant. Thesematrices of mutual
information and their differences were further mapped onto the crystal
structure.Graph analysiswas applied to detect hubs in the networks and
key allosteric communication pathways in PKA-C.SUPPLEMENTARY MATERIALS
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content/full/5/8/eaaw9298/DC1Walker et al., Sci. Adv. 2019;5 : eaaw9298 28 August 2019Fig. S1. [1H, 15N]-TROSY-HSQC spectra for PKA-CWT and PKA-CL205R in apo, ATPgN, and ATPgN/
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Fig. S2. CSPs observed upon ligand binding for PKA-CWT and PKA-CL205R.
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information (MutInf) analysis.
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